BDA retained by Langer Inc. to advise on strategic alternatives for Silipos

August 21, 2008 (PRLEAP.COM) Business News
Gray Hudkins, President and Chief Executive Officer, Langer, Inc. today stated "We remain very pleased with the performance and prospects for our Silipos business. We are committed to continuing our efforts to maximize shareholder value. We have retained Business Development Asia LLC to advise us on potential strategic alternatives for Silipos. As noted, this may include a sale of the business".

Euan Rellie, Senior Managing Director at Business Development Asia in New York is leading this assignment, with support from Melissa Wong, Associate and BDA's offices and network partners worldwide.

Langer, Inc., together with its wholly owned subsidiary Silipos, Inc. provides medical products to the long-term care, orthopedic, orthotic and prosthetic markets. Through its wholly owned subsidiaries Twincraft, Inc. and Silipos, Inc. the Company offers a diverse line of bar soap and other skincare products for the private label retail, medical and therapeutic markets. The Company sells its medical products primarily in the U.S. and Canada, and in more than 30 other countries, to national, regional, international and independent medical distributors and directly to healthcare professionals and patients. The Company sells its personal care products to branded consumer products companies, direct marketers, distribution partners, and specialty retailers. Langer is based in Deer Park, NY, with manufacturing facilities in Niagara Falls, NY, Winooski, VT and sales and marketing offices in Toronto, Canada; and New York, NY.

Silipos Inc., established in 1989, is a leader in skin protection and skin care. "Silipos' corporate slogan, Tomorrow's Technology for Today's Medical Challenges, expresses the company's commitment to a growing line of innovative Silipos Gel products." Silipos' proprietary Gel is a breakthrough in skin protection, used in over 200 Silipos products such as bandages, wraps, and pads. The Gel incorporates a medical grade mineral oil that gradually diffuses onto the skin to reduce friction and pressure, improve skin elasticity, and minimize scarring. Primary brands of Silipos product lines include: Silopad(tm), ComfortZone(tm), WonderZorb(tm), Wonderflex(tm), NouveauDerm(tm), Move®, Silosheath(tm), and Siloliner(tm). Silipos products are used in healthcare specialties including: Orthopedics, Podiatry, Wound Care, Burn Care, Prosthetics, Occupational Therapy, Physical Therapy, Plastic Surgery, Dermatology, Rheumatology, Sports Medicine, Cosmetology, and Home Health Care. Products are available through healthcare professionals and in stores selling home health supplies, pharmaceuticals, and sporting goods. They are sold in 60 countries. Geligne Medical*, a division of Silipos®, is devoted to cosmetic post-operative care and scar management. Silipos is an ISO 9001:2000 certified company whose products are CE marked.

Business Development Asia LLC was founded in 1996. BDA assists multinational corporate and financial sector clients to identify and execute acquisitions, divestments, JVs, restructuring and capital raising. The company is headquartered in New York with offices in London, Bahrain, Mumbai, Hong Kong, Shanghai, Seoul, and Tokyo. BDA employs 55 full-time professional staff across its eight offices, supplemented by senior advisors around the world. BDA's client list includes Air Products, Cadbury Schweppes, Celestica, DIC, DuPont, Ecolab, Global Power, Godrej, Great Lakes, Hanjin Shipping, Hercules, Huntsman, Inabata, Kimberly-Clark, Lear, Lubrizol, Mars, Molex, Morgan Stanley, Nalco, Reuters, Rohm & Haas, Ryder, Siemens, SigmaKalon, Sumitomo Chemical, Sun Chemical, TATA Auto Components, Tenneco, Tredegar, Visteon, WR Grace, and the British Government. Further information is available at

For more information, contact Euan Rellie at or Melissa Wong at on (1) 212 265 5300.